Tried to bring it under five at the close and complete failure, up in after hours.
You and your cabal of Funkmeisters could not manipulate higher volume moments after my post led to today's reversal, then everyone knew I was on to the day's trading manipulations, and this is your answer that NoMerritt won't be able to provide.
Did you enjoy his posts when he was short for six months and made his money at our expense while he lied repeatedly about our stock, did you enjoy his posts then as they turned out to be lies?
We don't cotton to liars around here, maybe that works for you, not round here though.
MoronicAnus aka. Funkmeister#3 have any of your brilliant posts ever led to a documented reversal from down 80 cents? Mine did in two minutes.... so I'm all growed up son.
Last 20 minutes shorts are trying desperately to hold down under $5, then they think that will lock out institutions, but it will not close under 5, you watch.
The above article was written a year and a half ago specifically about the trial that just completed in November and we'll get news on this any day.
Another Article that is very important:
From the Retina Today article:
Nearly all subjects (86%, 6 of 7 patients) receiving the 15-mg dose had a significant decrease in retinal thickness at 12 weeks, compared with 29% (2 of 7 patients) in the placebo group. Retinal volume also decreased in the 15-mg group compared with placebo (P = .05).
For BCVA change in ICD-9-CM vision loss, 36% of subjects improved at least 1 category with treatment. The placebo group had the lowest proportion of subjects with improvement (14%), whereas 47% of all patients treated with danazol improved by at least 1 category.
When the dose was adjusted for BMI in the trial just completed then these numbers will only get better, so you guys need to get ready for some great news on both Optina and Ampion
Seeking Alpha said Optina will dominate sales and kill Regeneron's sales of Eylea. Regeneron stock sells for $417 per share people check it out:
Optina is a pill being developed by Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) and it works with an entirely different mechanism where it actually repairs the leaking blood vessels by restoring the cytoskeletal system of the cells making up the leaking blood vessels in the eyes.
This strengthening of the cytoskeletal system allows the cells making up the blood vessels in the retina to anchor together tighter thereby stopping the leaking of blood and fluids. And it does so without any adverse side effects. Retina Today, a prominent scientific publication in ophthalmology, published a cover story titled, "Oral danazol (Optina) for DME." Shareholders are also concerned because Optina is in the 12th and final week of a pivotal trial and results will be known in the next month or two.
If trial results are favorable, then the likelihood of an FDA approval is very high because Optina is a repurposed drug. Optina is repurposed from an older drug called Danazol that was used to treat endometriosis. Danazol was FDA approved and found to be safe at a dosage of 800 MG per day. Optina is repurposed Danazol and is dosed at only between 20 to 40 MG per day meaning that it has no adverse side effects and safety has already been proven to the FDA. Earlier trials have shown efficacy and the current trial is expected to demonstrate both efficacy and safety.
Keep in mind that last year, after reviewing what must have been compelling data on Optina, the FDA assembled a large panel of 18 of its leading experts in this area and provided guidance to help structure the pivotal trials the drug is about to conclude.
If Optina is approved, it doesn't take a rocket scientist to figure out what will happen to Eylea and Lucentis sales. If you were suffering from Diabetic Macular Edema, and if Optina could treat you just as good what would you do?
3400/200 IS BACK those retractions are relentless today, the orderly flow of transactions are interrupted as a result and this is what is illegal.
still waiting for you to show me where I said all seeking alpha articles are whatever.... If you can't show me then you are a liar here as well. I'll be waiting.
3:04EST RETRACTIONS ALL DAY TODAY.
5600/800 AGAIN retracted, why not just buy, because their methodology is to drown out the next buyer who is confronted with fake bids.... lame
1200/300 continually retracted for four minutes won't allow for the next buyer to participate and yes our stock again was vulnerable to a three cent decline on few shares traded.
I guess you didn't like this response and opened up a whole new thread trying desperately to discredit my factual statements, you didn't realize on that thread that I would hammer you about you now did you?